研究

Jones DR, Opitz I, Harpole D, Yanagawa J, Lim E, Tsutani Y, Tan DSW, Dacic S, Ganti AK, Bodla S, Batig A, Lyfar P, Forcina A, Felip E.

TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.

Tsuchiya A, Utsunomiya H, Kamigaichi A, Tsutani Y, Hamada A, Takeuchi M, Hyodo Y, Mogami A, Takahari K, Ueda Y, Miyata Y, Okada M, Nakano Y.

Determinants and Mechanisms of Postoperative Effort Intolerance in Suspected Lung Cancer　- An Exercise-Stress Echocardiography Study.

Zhang Y, Zhang Q, Hao Y, Luo J, Piao Y, Wang W, Song Z, Li Z, Brcic L, Liu A, Yu J, Tsutani Y, et al.

International guidelines on the diagnosis and treatment of NUT carcinoma.

Hayasaka K, Shimokawa M, Haratake N, Notsuda H, Katsumata S, Hamada A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita I, Takamori S, Muto S, Takanashi Y, Mizuno K, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Shiono S, Soh J, Ohde Y, Okada Y.

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)

Fukami T, Tsutani Y.

Reply: Understanding Deauville score in stage I non-small cell lung cancer.

Toda M, Takada K, Nomura K, Kosai K, Hayasaka K, Watanabe T, Takamori S, Hamada A, Suda K, Ohara S, Ito M, Oiki H, Fukami T, Muto S, Katsumata S, Konno H, Toyoda T, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Takegahara K, Matsubara T, Kinoshita F, Akamine T, Nakamura R, Mizuno K, Nakagawa K, Kaneda S, Okada S, Notsuda H, Sakane T, Shinohara S, Abe M, Haratake N, Tane S, Hanawa R, Ito A, Namba K, Kawaguchi T, Minegishi K, Kurihara N, Iguchi T, Aokage K, Tsuboi M, Iwata T, Soh J, Shimokawa M, Ohde Y.

Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study

Tane S, Nishikubo M, Manabe T, Watanabe T, Nomura K, Hamada A, Takamori S, Katsumata S, Shimizu N, Kojima H, Takamori S, Muto S, Abe M, Yoshikawa M, Suzuki J, Toda M, Okada S, Kano S, Ohde Y, Maniwa Y.

Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study

Suda K, Sakai K, Ito M, Oiki H, Fukuda S, Ohara S, Hamada A, Chiba M, Shimoji M, Nishio K, Tsutani Y.

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation.

Noguchi M, Higashimoto Y, Takemoto T, Shiraishi M, Mizusawa H, Kanki K, Matsuzawa R, Tamaki A, Tsutani Y.

Association between preoperative diaphragmatic dome height for overall survival in patients with lung cancer and obstructive ventilatory disorder.

Takeno N, Nomura S, Shiiya H, Nagashima R, Chiba R, Ohtaka K, Fujiwara-Kuroda A, Shiina N, Ujiie H, Aragaki M, Takagi R, Kaji M, Kato T.

Comparative outcomes of lobectomy and combined segmentectomy in left upper-lobe lung cancer: a propensity score-matched analysis

Katsumata S, Kamigaichi A, Akamine T, Isaka M, Wakabayashi M, Mitome N, Yotsukura M, Mimae T, Hattori A, Miyoshi T, Endo M, Nakagawa K, Yoshioka H, Tsutani Y, Isaka T, Maniwa T, Shimada Y, Nakajima R, Suzuki K, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Sekino Y, Nakamura K, Fukuda H, Watanabe SI.

Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L.

Kawamura MM, Matsuoka M, Ujiie H, Ariga S, Nakazato S, Kato K, Hashimoto T, Matsuno Y, Kato T, Iwasaki N.

Cryptococcal Lung Infection Simulating Metastasis in a Myxoid Liposarcoma Patient: A Case Report

Akamine T, Hayasaka K, Takada K, Nomura K, Watanabe T, Takamori S, Katsumata S, Hamada A, Haratake N, Shimokawa M, Tsuboi M, Soh J, Ohde Y; CReGYT group.

Real-world outcomes of unresected non-small cell lung cancer following neoadjuvant chemoimmunotherapy

Takamori S, Tane S, Nishikubo M, Watanabe T, Nomura K, Hamada A, Takamori S, Katsumata S, Shiono S.

Clinical predictors of pathological response after immunotherapy in salvage surgery for non-small cell lung cancer: a supplementary analysis of the CReGYT-05 immune checkpoint inhibitor-salvage study

Ujiie H, Ito M, Oiki H, Fukuda S, Nishina M, Ohara S, Nishino M, Hamada A, Chiba M, Takemoto T, Tsutani Y.

The Hisashi technique: Making a "pent roof" for safe and curative lung segmentectomy.

Harada H, Miyawaki T, Ohde Y, Chiba Y, Hayashi H, Tsutani Y, Tanaka K, Matsumoto K, Oshima M, Miura S, Aoki T, Sato Y, Aiba T, Azuma K, Yamaguchi M, Yamamoto N, Kenmotsu H.

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer: TRAP-OLIGO study (WJOG11118L)

Cummings AL, Clay TD, Lee JM, Chaft JE, Shum E, Tan DSW, Remon Masip J, Zhou C, Tsutani Y, Carrasco CP, Tort Piella A, Eigenbrod-Giese S, Luecke S, Lunger L, Nadal E.

Beamion LUNG-3: Zongertinib in resectable HER2-mutant NSCLC

Sasaki A, Shiiya H, Ujiie H, Hirata K, Ogawa T, Narita S, Otsuka S, Yamasaki H, Ohtaka K, Fujiwara-Kuroda A, Aragaki M, Kato T.

FDG-PET/CT data enhances machine learning prediction of occult lymph-node metastasis in lung adenocarcinoma

Mitome N, Hamada A, Wakabayashi M, Uozumi T, Horinouchi H, Isaka M, Yotsukura M, Aokage K, Fukuda H, Watanabe SI, Tsutani Y; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG).

A Multi-Institutional Randomized Phase III Trial of Neoadjuvant Chemoimmunotherapy Followed By Surgery Versus Upfront Surgery in Patients With Resectable Clinical Stage II-III Non-Small Cell Lung Cancer: JCOG2317 (NATCH-ICI).

Onodera K, Aokage K, Saji H, Wakabayashi M, Endo M, Tsutani Y, Nakagawa K, Shimada Y, Isaka T, Isaka M, Nakajima R, Hattori A, Maniwa T, Mimae T, Miyoshi T, Yoshioka H, Yotsukura M, Mitome N, Uozumi T, Fukuda H, Watanabe SI, Suzuki K.

Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211

Takada K, Koga T, Nomura K, Matsubara T, Hayakawa T, Fujikawa R, Hamada A, Fujino K, Katsumata S, Watanabe H, Suzuki J, Kinoshita F, Haratake N, Abe M, Takamori S, Tane S, Hoshino H, Tsuchida H, Muto S, Endo M, Takenaka T, Yoshizumi T, Shimokawa M, Soh J, Ohde Y.

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study)

Isaka T, Kenmotsu H, Wakabayashi M, Yoshioka H, Shimada Y, Tsutani Y, Nakagawa K, Yotsukura M, Mitome N, Uozumi T, Daga H, Tanaka H, Kasai T, Niho S, Tsuboi M, Fukuda H, Aokage K, Okamoto I, Watanabe SI.

Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206

Canaslan K, Yetginoğlu Ö, Tsutani Y, Sharma A, Mansila DE, Emami A, Abolhassani H, Ardeshir-Larijani F.

Precision Oncology in Thymic Epithelial Tumors: Therapeutic Horizons and Implementation Barriers